PHARMACOLOGY OF GR203040, A POTENT AND SELECTIVE NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST

被引：0
|
作者：
BEATTIE, DT
CONNER, HE
HAWCOCK, AB
PERREN, MJ
WARD, P
机构：
[1] GLAXO RES & DEV LTD,DEPT PHARMACOL,STEVENAGE SG1 2NY,HERTS,ENGLAND
[2] GLAXO RES & DEV LTD,DEPT MED CHEM,STEVENAGE SG1 2NY,HERTS,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [21] Synthesis of carbon-14 labelled NK-1 receptor antagonists GR203040 and GR205171
    Cable, Karl M.
    Wells, Guy N.
    Sutherland, Derek R.
    Journal of Labelled Compounds and Radiopharmaceuticals, 2000, 43 (01) : 29 - 45
  • [22] The tachykinin NK1 receptor in the brain:: pharmacology and putative functions
    Saria, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) : 51 - 60
  • [23] Opioid activity of sendide, a tachykinin NK1 receptor antagonist
    Sakurada, T
    Yuhki, M
    Inoue, M
    Sakurada, C
    Koichi, TN
    Ohba, M
    Kisara, K
    Sakurada, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 369 (03) : 261 - 266
  • [24] IN-VITRO AND IN-VIVO BIOLOGICAL-ACTIVITIES OF SR140333, A NOVEL POTENT NONPEPTIDE TACHYKININ NK1, RECEPTOR ANTAGONIST
    EMONDSALT, X
    DOUTREMEPUICH, JD
    HEAULME, M
    NELIAT, G
    SANTUCCI, V
    STEINBERG, R
    VILAIN, P
    BICHON, D
    DUCOUX, JP
    PROIETTO, V
    VANBROECK, D
    SOUBRIE, P
    LEFUR, G
    BRELIERE, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (03) : 403 - 413
  • [25] IN-VITRO AND IN-VIVO PHARMACOLOGY OF THE NONPEPTIDE ANTAGONIST AT TACHYKININ NK(2) RECEPTORS, GR159897
    BALL, DI
    BERESFORD, IJM
    WREN, GPA
    PENDRY, YD
    SHELDRICK, RLG
    WALSH, DM
    TURPIN, MP
    HAGAN, RM
    COLEMAN, RA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U26 - U26
  • [26] In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist
    Robineau, P
    Lonchampt, M
    Kucharczyk, N
    Krause, JE
    Regoli, D
    Fauchere, JL
    Prost, JF
    Canet, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) : 677 - 684
  • [27] SCH 206272:: a potent, orally active tachykinin NK1, NK2, and NK3 receptor antagonist
    Anthes, JC
    Chapman, RW
    Richard, C
    Eckel, S
    Corboz, M
    Hey, JA
    Fernandez, X
    Greenfeder, S
    McLeod, R
    Sehring, S
    Rizzo, C
    Crawley, Y
    Shih, NY
    Piwinski, J
    Reichard, G
    Ting, P
    Carruthers, N
    Cuss, FM
    Billah, M
    Kreutner, W
    Egan, RW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (02) : 191 - 202
  • [28] Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist
    Grélot, L
    Dapzol, J
    Estève, E
    Frugière, A
    Bianchi, AL
    Sheldrick, RLG
    Gardner, CJ
    Ward, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (08) : 1643 - 1650
  • [29] SR-142801, THE FIRST POTENT NONPEPTIDE ANTAGONIST OF THE TACHYKININ NK3 RECEPTOR
    EMONDSALT, X
    BICHON, D
    DUCOUX, JP
    HEAULME, M
    MILOUX, B
    PONCELET, M
    PROIETTO, V
    VANBROECK, D
    VILAIN, P
    NELIAT, G
    SOUBRIE, P
    LEFUR, G
    BRELIERE, JC
    LIFE SCIENCES, 1994, 56 (01) : PL27 - PL32
  • [30] GR159897, A POTENT NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST, RELEASES SUPPRESSED BEHAVIORS IN A NOVEL AVERSIVE ENVIRONMENT
    STRATTON, SC
    BERESFORD, IJM
    HAGAN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U27 - U27
12345